Caxton Associates LLP Haemonetics Corp Transaction History
Caxton Associates LLP
- $2.87 Trillion
- Q1 2025
A detailed history of Caxton Associates LLP transactions in Haemonetics Corp stock. As of the latest transaction made, Caxton Associates LLP holds 3,397 shares of HAE stock, worth $235,683. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,397Holding current value
$235,683% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HAE
# of Institutions
352Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$413 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$354 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$302 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$182 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$152 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.56B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...